A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene.
Y Guilloux, S Lucas, VG Brichard, A Van Pel… - The Journal of …, 1996 - rupress.org
Y Guilloux, S Lucas, VG Brichard, A Van Pel, C Viret, E De Plaen, F Brasseur, B Lethé…
The Journal of experimental medicine, 1996•rupress.orgA cytolytic T lymphocyte (CTL) clone that lyses many HLA-A2 melanomas was derived from
a population of tumor-infiltrating lymphocytes of an HLA-A2 melanoma patient. The gene
coding for the antigen recognized by this CTL was identified by transfection of a cDNA
library. It is the gene which has been reported to code for N-acetylglucosaminyltransferase V
(GnT-V). Remarkably, the antigenic peptide recognized by the CTL is encoded by a
sequence located in an intron. In contrast to the fully spliced GnT-V mRNA, which was found …
a population of tumor-infiltrating lymphocytes of an HLA-A2 melanoma patient. The gene
coding for the antigen recognized by this CTL was identified by transfection of a cDNA
library. It is the gene which has been reported to code for N-acetylglucosaminyltransferase V
(GnT-V). Remarkably, the antigenic peptide recognized by the CTL is encoded by a
sequence located in an intron. In contrast to the fully spliced GnT-V mRNA, which was found …
A cytolytic T lymphocyte (CTL) clone that lyses many HLA-A2 melanomas was derived from a population of tumor-infiltrating lymphocytes of an HLA-A2 melanoma patient. The gene coding for the antigen recognized by this CTL was identified by transfection of a cDNA library. It is the gene which has been reported to code for N-acetylglucosaminyltransferase V (GnT-V). Remarkably, the antigenic peptide recognized by the CTL is encoded by a sequence located in an intron. In contrast to the fully spliced GnT-V mRNA, which was found in a wide range of normal and tumoral tissues, the mRNA containing the intron region coding for the antigen was not found at a significant level in normal tissues. This mRNA was observed to be present in about 50% of melanomas. Our results suggest that a promoter located near the end of the relevant intron is activated in melanoma cells, resulting in the production of an mRNA coding for the antigen.
rupress.org